Tranquility Partners’s AstraZeneca AZN Stock Holding History

Tranquility Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$394K	Buy	2,434 +942	+63%	+$157K	0.14%	156
2026 Q2	$283K	Buy	1,492 +112	+8%	+$21.1K	0.1%	199
2026 Q1	$272K	Buy	+1,380	New	+$266K	0.1%	198
2023 Q1	–	Sell	-3,642	Closed	-$494K	–	208
2022 Q4	$494K	Hold	3,642	–	–	0.25%	107
2022 Q3	$399K	Hold	3,642	–	–	0.22%	115
2022 Q2	$481K	Buy	3,642 +924	+34%	+$121K	0.25%	113
2022 Q1	$361K	Hold	2,718	–	–	0.17%	138
2021 Q4	$317K	Sell	2,718 -150	-5%	-$17.6K	0.15%	153
2021 Q3	$344K	Hold	2,868	–	–	0.17%	143
2021 Q2	$344K	Buy	2,868 +93	+3%	+$10.2K	0.19%	133
2021 Q1	$276K	Buy	+2,775	New	+$279K	0.17%	149

Other funds holding AZN

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.31B AUM 25.55% 1-Year Est. Return

Oslo Pensjonsforsikring Oslo $863M AUM 18.29% 1-Year Est. Return

Tranquility Partners's AZN Position: Q3 2026 in Review

Tranquility Partners increased its AstraZeneca (AZN) stake by 63% in Q3 2026, buying an estimated $157K and bringing the position to 2,434 shares worth $394K. The position accounts for 0.14% of the portfolio, ranked #156.

Tranquility Partners first reported a position in AZN in Q1 2021 and has held it in 11 quarters since. The position peaked at $494K in Q4 2022. 250 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

Tranquility Partners held 2,434 shares of AstraZeneca worth $394K as of Q3 2026.
Tranquility Partners bought 942 AstraZeneca shares in Q3 2026, an estimated $157K.
AstraZeneca made up 0.14% of Tranquility Partners's portfolio in Q3 2026, its #156 holding.
Tranquility Partners first reported a position in AstraZeneca in Q1 2021 and has held it in 11 quarters since.
Tranquility Partners's AstraZeneca position peaked at $494K in Q4 2022.
250 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Tranquility Partners's 13F filing for Q3 2026, filed 20 Oct 2026.